Abe Hideyuki相关文献与解析，生知库 | 链接生命科学的每一步

Fujiyoshi Kenji, Sugihara Rie, Miyamoto Naoki, Watanabe Yoriko, Sudo Tomoya, Numata Sanae, Akiba Jun, Abe Hideyuki, Ichinose Yuka, Inoue Kenji, Ozono Shuichi, Ono Takeharu, Orioka Kentaro, Kashihara Masaki, Kajiwara Ryousuke, Kawano Hiroyuki, Kawahara Akihiko, Takase Ryuta, Toh Uhi, Hashimoto Kazuaki, Hisaka Toru, Hirai Shingo, Mitsuoka Masahiro, Miyazaki Daiki, Yoshitomi Fumi, Yamamoto Ken, Umeno Hirohito, Nomura Masahisa, Naito Yoshiki

肿瘤

肿瘤免疫

发表日期：2025

文献求助收藏

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival

转移性肾细胞癌中腺苷2A受体表达增加与抗血管内皮生长因子药物和抗PD-1/抗CTLA-4抗体疗效较差以及生存期缩短相关。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-020-02843-x

Kamai, Takao; Kijima, Toshiki; Tsuzuki, Toyonori; Nukui, Akinori; Abe, Hideyuki; Arai, Kyoko; Yoshida, Ken-Ichiro

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density

上尿路尿路上皮癌中程序性细胞死亡蛋白1配体1表达升高与肿瘤进展和肿瘤浸润淋巴细胞密度增加相关

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-020-02499-7

Nukui, Akinori; Kamai, Takao; Arai, Kyoko; Kijima, Toshiki; Kobayashi, Minoru; Narimatsu, Takahiro; Kambara, Tsunehito; Yuki, Hideo; Betsunoh, Hironori; Abe, Hideyuki; Fukabori, Yoshitatsu; Yashi, Masahiro; Yoshida, Ken-Ichiro

Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas

GLUT1在假栅状和血管周围肿瘤细胞中的表达是胶质母细胞瘤患者的独立预后因素

期刊:Journal of Neuropathology and Experimental Neurology

影响因子:3

doi:10.1093/jnen/nly124

Komaki, Satoru; Sugita, Yasuo; Furuta, Takuya; Yamada, Kyohei; Moritsubo, Mayuko; Abe, Hideyuki; Akiba, Jun; Miyagi, Naohisa; Nakamura, Hideo; Miyoshi, Hiroaki; Ohshima, Koichi; Morioka, Motohiro

5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase

以5-氟尿嘧啶为基础的辅助化疗可改善伴有淋巴血管侵犯的上尿路癌患者以及二氢嘧啶脱氢酶低表达患者的临床预后。

期刊:Oncology Letters

影响因子:2.2

doi:10.3892/ol.2019.10086

Narimatsu, Takahiro; Kambara, Tsunehito; Abe, Hideyuki; Uematsu, Toshitaka; Tokura, Yuumi; Suzuki, Issei; Sakamoto, Kazumasa; Takei, Kouhei; Nishihara, Daisaku; Nakamura, Gaku; Kokubun, Hidetoshi; Yuki, Hideo; Betsunoh, Hironori; Kamai, Takao

Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis

新辅助放化疗对临界可切除胰头癌的意义：病理局部侵袭和微血管侵袭分析

期刊:Molecular and Clinical Oncology

影响因子:1.4

doi:10.3892/mco.2019.1885

Naito, Yoshiki; Ishikawa, Hiroto; Sadashima, Eiji; Okabe, Yoshinobu; Takahashi, Kenjiro; Kawahara, Ryuichi; Hisaka, Toru; Fukahori, Masaru; Ushijima, Tomoyuki; Ishida, Yusuke; Tanigawa, Masahiko; Mihara, Yutaro; Nakayama, Masamichi; Kondo, Reiichiro; Kusano, Hironori; Takase, Yorihiko; Abe, Hideyuki; Ogo, Etsuyo; Okuda, Koji; Shimamatsu, Kazuhide; Yano, Hirohisa; Akiba, Jun

Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer

核因子E2相关因子2表达升高与葡萄糖摄取增加和上尿路癌进展存在临床意义上的关联。

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-018-4427-1

Nukui, Akinori; Narimatsu, Takahiro; Kambara, Tsunehito; Abe, Hideyuki; Sakamoto, Setsu; Yoshida, Ken-Ichiro; Kamai, Takao

Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma

干扰素λ3的种系多态性与肾细胞癌的进展在临床上相关。

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.23683

Nukui, Akinori; Yanai, Yoshiaki; Tsuzuki, Toyonori; Abe, Hideyuki; Arai, Kyoko; Yoshida, Ken-Ichiro; Kamai, Takao

Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis

肾细胞癌中Nrf2表达增加与术后慢性肾脏病和不良预后相关。

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.25322

Yuki, Hideo; Kamai, Takao; Murakami, Satoshi; Higashi, Satoru; Narimatsu, Takahiro; Kambara, Tsunehito; Betsunoh, Hironori; Abe, Hideyuki; Arai, Kyoko; Shirataki, Hiromichi; Yoshida, Ken-Ichiro

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy

血清中可溶性白细胞介素-2受体水平升高与转移性透明细胞肾细胞癌对干扰素α和序贯VEGF靶向治疗的反应较差相关。

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-017-3369-3

Nukui, Akinori; Masuda, Akinori; Abe, Hideyuki; Arai, Kyoko; Yoshida, Ken-Ichiro; Kamai, Takao

Comprehensive genetic profiling using tissue and blood in locally advanced tumors.

利用组织和血液对局部晚期肿瘤进行全面的基因分析

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival

转移性肾细胞癌中腺苷2A受体表达增加与抗血管内皮生长因子药物和抗PD-1/抗CTLA-4抗体疗效较差以及生存期缩短相关。

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density

上尿路尿路上皮癌中程序性细胞死亡蛋白1配体1表达升高与肿瘤进展和肿瘤浸润淋巴细胞密度增加相关

Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas

GLUT1在假栅状和血管周围肿瘤细胞中的表达是胶质母细胞瘤患者的独立预后因素

5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase

以5-氟尿嘧啶为基础的辅助化疗可改善伴有淋巴血管侵犯的上尿路癌患者以及二氢嘧啶脱氢酶低表达患者的临床预后。

Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis

新辅助放化疗对临界可切除胰头癌的意义：病理局部侵袭和微血管侵袭分析

Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer

核因子E2相关因子2表达升高与葡萄糖摄取增加和上尿路癌进展存在临床意义上的关联。

Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma

干扰素λ3的种系多态性与肾细胞癌的进展在临床上相关。

Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis

肾细胞癌中Nrf2表达增加与术后慢性肾脏病和不良预后相关。

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy

血清中可溶性白细胞介素-2受体水平升高与转移性透明细胞肾细胞癌对干扰素α和序贯VEGF靶向治疗的反应较差相关。